Bryan Kobel
Chief Executive Officer bei TC BIOPHARM (HOLDINGS) PLC
Vermögen: 773 $ am 30.11.2023
Ursprung des Netzwerks ersten Grades von Bryan Kobel
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 9 | |
TCB Newco Ltd.
TCB Newco Ltd. Pharmaceuticals: MajorHealth Technology TCB Newco Ltd. provides clinical services. It develops CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. The company was founded on July 5, 2021 and is headquartered in Motherwell, GB.
9
| Private Company | Pharmaceuticals: Major | 9 |
Laidlaw & Co. (UK) Ltd.
Laidlaw & Co. (UK) Ltd. Investment Banks/BrokersFinance Part of Laidlaw Holdings Ltd., Laidlaw & Co. (UK) Ltd. is a British company that provides investment advice. The private company is based in London, UK. The company was founded in 1842. Matthew D. Eitner has been the CEO of the company since 2010.
2
| Subsidiary | Investment Banks/Brokers | 2 |
The Alberleen Group LLC
The Alberleen Group LLC Investment Banks/BrokersFinance The Alberleen Group LLC provides investment banking services. The firm offers mergers, acquisitions advice, capital raising services, investment opportunities and merchant banking services. It serves to the energy, financials, healthcare, real estate industries. The company was founded by Jolyne Caruso in July 2010 and is headquartered in New York, NY.
1
| Private Company | Investment Banks/Brokers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bryan Kobel
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ATHENEXPAR | Pharmaceuticals: Major | Investor Relations Contact | |
Atlantic Healthcare Plc
Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
Cingulate Therapeutics LLC
Cingulate Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cingulate Therapeutics LLC operates as a biopharmaceutical company. It focuses on the development of new products for the treatment of central nervous system and neurobiological disorders. The company was founded by Shane J. Schaffer, Patrick Joseph Gallagher, Matthew Brams, Arthur B. Sthraughn, Craig S. Gilgallon and Raul R. Silva and is headquartered in Kansas City, KS. | Pharmaceuticals: Major | Founder | |
Institute of Chartered Accountants in England & Wales
Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Aberdeen | College/University | Graduate Degree | |
The University of Edinburgh | College/University | Doctorate Degree | |
New York University | College/University | Masters Business Admin | |
The Pennsylvania State University | College/University | Masters Business Admin | |
University of Vermont | College/University | Undergraduate Degree | |
University of Mumbai | College/University | Undergraduate Degree | |
Heriot-Watt University | College/University | Undergraduate Degree | |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Kidder, Peabody & Co., Inc.
Kidder, Peabody & Co., Inc. Investment Banks/BrokersFinance Kidder, Peabody & Co., Inc. provides security brokerage services. The private company is based in Buffalo, NY and has subsidiaries in Switzerland. The company was founded by Thomas W. Ostrander. | Investment Banks/Brokers | Corporate Officer/Principal | |
Expedeon Ltd.
Expedeon Ltd. BiotechnologyHealth Technology Expedeon Ltd. develops and produces proteins for drug discovery. Its products include gel electrophoresis, nucleic acid kits, protein quantitation, western blotting reagents and spectroscopy. The firm provides genomics and proteomics tools to scientists. The company was founded by Heikki Lanckriet in 2003 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Safeguard Biosystems Holdings Ltd.
Safeguard Biosystems Holdings Ltd. Medical SpecialtiesHealth Technology Safeguard Biosystems Holdings Ltd. engages in the development, manufacture, and sales of diagnostic tests for human and animal health; and food safety products. The company was founded on May 11, 2006 and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member | |
Jefferies International Ltd.
Jefferies International Ltd. Investment Banks/BrokersFinance Jefferies International Ltd. (JIL) is a brokerage firm headquartered in London, UK. The firm was founded in 1986 and is a subsidiary of Jefferies Holdings II Ltd., ultimately held by Jefferies Financial Group, Inc. (NYSE: JEF) in the US. JIL provides broking services to various investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
ACTINIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Jamess Capital Group LLC | Corporate Officer/Principal | ||
RELMADA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
INNOCOLL HOLDINGS PLC | Pharmaceuticals: Major | Director/Board Member | |
TC Biopharm Ltd.
TC Biopharm Ltd. Miscellaneous Commercial ServicesCommercial Services TC Biopharm Ltd. provides research services. The firm specializes in clinical grade cell therapy, cancer immonotherapy, regenerative medicine, and stratified medicine. The company was founded by Michael Leek, Angela Scott and David Galagher in 2014 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Luperacus Ltd.
Luperacus Ltd. BiotechnologyHealth Technology Luperacus Ltd. develops novel therapeutic antibodies to treat canine and human cancer. The company was founded by Alan G. Clark and is headquartered in Glasgow, the United Kingdom. | Biotechnology | Director/Board Member | |
Glykogen Ltd.
Glykogen Ltd. Pharmaceuticals: MajorHealth Technology Glykogen Ltd. engages in the development of anti-glycan monoclonal antibodies using a novel and innovative process. The company was founded on October 11, 2016 and is headquartered in Fife, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Hox Therapeutics Ltd.
Hox Therapeutics Ltd. BiotechnologyHealth Technology Hox Therapeutics Ltd. develops therapeutics for cancer diseases based on the role of HOX genes. The private company is based in Guildford, UK. | Biotechnology | Chairman | |
Algorithm Sciences, Inc.
Algorithm Sciences, Inc. Pharmaceuticals: MajorHealth Technology Algorithm Sciences, Inc. engages in the business of technology services. The company was founded in 2019 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
CINGULATE INC. | Pharmaceuticals: Major | Director/Board Member | |
Cingulate Works, Inc.
Cingulate Works, Inc. Pharmaceuticals: MajorHealth Technology Cingulate Works, Inc. is a clinical stage biopharmaceutical company which operates drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products. Its products designed to improve the lives of patients suffering from burdensome daily dosing regimens and suboptimal treatment outcomes. The company was founded by Shane J. Schaffer, Matthew N. Brams, Raul R. Silva & Craig Steven Gilgallon in 2013 and is headquartered in Kansas City, KS. | Pharmaceuticals: Major | Director/Board Member | |
QUOIN PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Director/Board Member | |
ILC Therapeutics Ltd.
ILC Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services ILC Therapeutics Ltd. is a British biotechnology company that conducts research and experimental development. The company is based in Lanarkshire, UK. The company was founded by William H. Stimson. Alan Keith Walker has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Director/Board Member |
Statistik
International
Vereinigte Staaten | 28 |
Vereinigtes Königreich | 16 |
Irland | 3 |
Indien | 2 |
Sektoral
Health Technology | 24 |
Finance | 9 |
Consumer Services | 8 |
Commercial Services | 7 |
Operativ
Director/Board Member | 69 |
Corporate Officer/Principal | 30 |
Independent Dir/Board Member | 20 |
Chairman | 15 |
Chief Executive Officer | 13 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Arlene Morris | 28 |
Patrick Gallagher | 20 |
Anthony Culverwell | 18 |
Martin Thorp | 15 |
Edward Niemczyk | 13 |
Sandesh Seth | 10 |
Mark Bonyhadi | 9 |
Alan George Clark | 7 |
Angela Scott | 7 |
Michael Leek | 5 |
Kimihito Minoura | 4 |
Jolyne Caruso | 3 |
Sebastian Wanless | 3 |
Lorraine Christie Porter | 2 |
Dorothy Lister | 2 |
- Börse
- Insiders
- Bryan Kobel
- Unternehmensverbindungen